@article{TLCR17155,
author = {Paul Jules Van Houtte and Daniel Devriendt},
title = {Can we omit radiotherapy in case of brain metastases for patients with mutant EGFR lung adenocarcinoma?},
journal = {Translational Lung Cancer Research},
volume = {6},
number = {Suppl 1},
year = {2017},
keywords = {},
abstract = {The paper presented by Magnuson et al. is a multiinstitutional retrospective study looking to the treatment of brain metastases among patients with tyrosine kinase inhibitor naive epidermal growth factor mutant non-small cell lung cancer: they concluded that deferral of radiotherapy is associated with inferior survival and the best approach is radiosurgery (RS) followed by EGFR-TKI to avoid the neurocognitive toxicity of whole brain radiotherapy (WBRT) (1).},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/17155}
}